LUCD vs ZBH · rev $2.7M vs P/E 23, rev $4.26B
Lucid Diagnostics Inc (LUCD) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Lucid Diagnostics Inc (LUCD) is a medical devices company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported LUCD revenue for 2026-06-30 was $2.7M. Net income was -$25.6M. LUCD currently screens at market cap $123.3M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
LUCD currently screens at market cap $123.3M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the LUCD and ZBH stock pages for the full models.
Not investment advice.